+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Artificial Intelligence In Diagnostics Market by Component, by Diagnosis Type, and by Region - Global Forecast to 2023-2033

  • PDF Icon

    Report

  • 200 Pages
  • January 2023
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5717235
The artificial intelligence in diagnostics market size is estimated to be USD 605.25 million in 2022 and is expected to witness a CAGR of 26.71% during the forecast period 2023-2033. Increasing demand for low-cost diagnostic techniques, effective & efficient report analysis, and fast diagnostic data generation are some of the factors projected to drive the market growth in near future. Furthermore, technological improvements in computer processing, cloud storage, and machine learning algorithm and introduction of startups and increasing awareness in the form of funding & investment are other factors supporting the market growth. However, lack of skilled professional and issues related to data security are predicted to limit market growth.

Technological improvements in computer processing, cloud storage, and machine learning algorithm is expected to fuel the market growth during the forecast period. This enables care professionals to develop timely & suitable treatment plans. AI-based algorithms are being widely used in pathology and radiology services. For instance, AI-driven radiology systems can gather several datasets from imaging modalities and accurately analyze them with the help of the radiologist. The integration of AI in pathology is also the subject of numerous research investigations, some of which focus on the identification of metastatic breast cancer and chronic kidney disease and kidney function testing.

Introduction of startups and increasing awareness in the form of funding & investment is predicted to propel the market growth during the projected period. Rapid adoption of AI-powered technologies in healthcare firms has been rewarded with favourable government assistance and funding from private investors and venture capitalists. For instance, in May 2020, Arterys raised USD 28 million in Series C funding, driven by Temasek Holdings and Benslie Investment Group, to increase the scope of its product line.

Segmentation

By Component

The market is categorized into services, software, and hardware. In 2022, the software segment accounted for the highest revenue share due to the rising demand for AI-enabled diagnostics solutions to provide correct diagnosis. A wide range of acute and chronic disorders are being rapidly detected in the world's population, which is anticipated to increase demand for advanced AI-enabled solutions. The rising demand for AI-based solutions as a result of the increasing burden on healthcare systems and the lack of qualified healthcare workers making the current healthcare workforce more inclined to burnout. Continuous improvements in healthcare infrastructure and Electronic Health Records (EHRs) using AI-based solutions are also anticipated to support the growth of this market.

By Diagnosis Type

The market is segmented into oncology, cardiology, radiology, chest and lung, neurology, pathology, and others. In the global market, the neurology segment accounted for the largest revenue share in 2022 owing to increasing prevalence of neurological disorders. The adoption of value-based care as a growing trend in addressing the incidence of neurological disorders is accelerating the segment's growth. The expansion of this market is being driven by the development of complex deep neural networks and cutting-edge algorithms that have been trained on numerous picture datasets obtained for various evaluations and diagnosis. AI-based diagnostic options in neurology increase precision and accuracy and productivity and clinical opinion of the radiologist. The improvement of neurological departments has been boosted by the widespread usage of AI-enabled solutions.

Regional Markets

In 2022, North America region accounted for the highest revenue in the artificial intelligence in diagnostics market and is expected to maintain its dominance during the forecast period. This is attributed to existence of a well-established healthcare IT infrastructure, ongoing technological developments, soaring digital literacy, the emergence of startups, supportive government initiatives, expanding funding options, and presence of important players in the region. However, Asia Pacific is expected to experience the fastest rate of growth over the projection period. The increase in the number of public and private initiatives supporting the adoption of AI-based diagnostic solutions is responsible for this expansion. Additionally, the expansion of the regional industry is being supported by the creation of startups and rising recognition and investment. Additionally, the development of regional markets is influenced by the accessibility of private funding and startup incubators. The higher incidence of acute & chronic disorders in the region together with the ageing population base is also anticipated to support market expansion.

Competitor Insights

Some of the key players operating in the artificial intelligence in diagnostics market are Digital Diagnostics, Inc., AliveCor, Inc., Siemens Healthineers, Vuni, Inc., Neural Analytics, Zebra Medical Vision, Inc, Riverain Technologies, GE Healthcare, Aidoc, and Imagen Technologies.

To achieve a competitive edge, these companies are implementing a variety of growth strategies. Strategic partnerships, alliances, and agreements with different businesses and research institutions are seen to be the main strategies used by companies in this sector.

In order to create a pathway for artificial intelligence (AI) and digital technologies in cardiology and create innovative approaches for better health outcomes, GE Healthcare and the American College of Cardiology (ACC) collaborated in June 2021.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including component and diagnosis type from 2022 to 2033.

Segmentation: Artificial Intelligence In Diagnostics Market Report 2022 - 2033

Component (Revenue, USD Million), 2022 - 2033

  • Services
  • Software
  • Hardware

Diagnosis Type (Revenue, USD Million), 2022 - 2033

  • Oncology
  • Cardiology
  • Radiology
  • Chest and Lung
  • Neurology
  • Pathology
  • Others

By Region (Revenue, USD Million), 2022 - 2033

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Framework
1.3.1. Research Models
1.3.1.1. Bottom-up Approach
1.3.1.2. Top-down Approach
1.3.1.3. Data Triangulation
1.3.2. Data Analysis
1.3.2.1. Data Validation
1.3.2.2. Market Size Estimation
1.3.2.3. Market Forecast Model

2. Introduction: Autosamplers

3. Executive Summary

4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.1.5. Driver 5
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.2.4. Restraint 4
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.3.4. Opportunity 4
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.4.4. Trend 4
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3
4.5.4. Challenge 4

5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. SWOT Analysis

6. COVID-19 Impact Analysis: Artificial Intelligence In Diagnostics Market

7. Market Analysis by Component
7.1. Services
7.1.1. Services Market Forecast, 2022-2033 (USD Million)
7.2. Software
7.2.1. Software Market Forecast, 2022-2033 (USD Million)
7.3. Hardware
7.3.1. Hardware Market Forecast, 2022-2033 (USD Million)

8. Market Analysis by Diagnosis Type
8.1. Oncology
8.1.1. Oncology Market Forecast, 2022-2033 (USD Million)
8.2. Cardiology
8.2.1. Cardiology Market Forecast, 2022-2033 (USD Million)
8.3. Radiology
8.3.1. Radiology Market Forecast, 2022-2033 (USD Million)
8.4. Chest and Lung
8.4.1. Chest and Lung Market Forecast, 2022-2033 (USD Million)
8.5. Neurology
8.5.1. Neurology Market Forecast, 2022-2033 (USD Million)
8.6. Pathology
8.6.1. Pathology Market Forecast, 2022-2033 (USD Million)
8.7. Others
8.7.1. Others Market Forecast, 2022-2033 (USD Million)

8. Regional Market Analysis
8.1. Regional Market Trends

9. North America Artificial Intelligence In Diagnostics Market
9.1. North America Artificial Intelligence In Diagnostics Market
9.1.1. North America Market Size and Forecast, 2022-2033 (USD Million)
9.1.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
9.1.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)
9.2. U.S. Artificial Intelligence In Diagnostics Market
9.2.1. U.S. Market Size and Forecast, 2022-2033 (USD Million)
9.2.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
9.2.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)
9.3. Canada Artificial Intelligence In Diagnostics Market
9.3.1. Canada Market Size and Forecast, 2022-2033 (USD Million)
9.3.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
9.3.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)

10. Europe Artificial Intelligence In Diagnostics Market
10.1. Europe Artificial Intelligence In Diagnostics Market
10.1.1. Europe Market Size and Forecast, 2022-2033 (USD Million)
10.1.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
10.1.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)
10.2. Germany Artificial Intelligence In Diagnostics Market
10.2.1. Germany Market Size and Forecast, 2022-2033 (USD Million)
10.2.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
10.2.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)
10.3. UK Artificial Intelligence In Diagnostics Market
10.3.1. UK Market Size and Forecast, 2022-2033 (USD Million)
10.3.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
10.3.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)
10.4. France Artificial Intelligence In Diagnostics Market
10.4.1. France Market Size and Forecast, 2022-2033 (USD Million)
10.4.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
10.4.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)
10.5. Spain Artificial Intelligence In Diagnostics Market
10.5.1. Spain Market Size and Forecast, 2022-2033 (USD Million)
10.5.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
10.5.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)
10.6. Italy Artificial Intelligence In Diagnostics Market
10.6.1. Italy Market Size and Forecast, 2022-2033 (USD Million)
10.6.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
10.6.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)
10.7. Rest of Europe Artificial Intelligence In Diagnostics Market
10.7.1. Rest of Europe Market Size and Forecast, 2022-2033 (USD Million)
10.7.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
10.7.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)

11. Asia Pacific Artificial Intelligence In Diagnostics Market
11.1. Asia Pacific Artificial Intelligence In Diagnostics Market
11.1.1. Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
11.1.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
11.1.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)
11.2. Japan Artificial Intelligence In Diagnostics Market
11.2.1. Japan Market Size and Forecast, 2022-2033 (USD Million)
11.2.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
11.2.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)
11.3. China Artificial Intelligence In Diagnostics Market
11.3.1. China Market Size and Forecast, 2022-2033 (USD Million)
11.3.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
11.3.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)
11.4. India Artificial Intelligence In Diagnostics Market
11.4.1. India Market Size and Forecast, 2022-2033 (USD Million)
11.4.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
11.4.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)
11.5. South Korea Artificial Intelligence In Diagnostics Market
11.5.1. South Korea Market Size and Forecast, 2022-2033 (USD Million)
11.5.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
11.5.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)
11.5.1.3. Market Size and Forecast by Device, 2022-2033 (USD Million)
11.6. Australia Artificial Intelligence In Diagnostics Market
11.6.1. Australia Market Size and Forecast, 2022-2033 (USD Million)
11.6.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
11.6.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)
11.7. Rest of Asia Pacific Artificial Intelligence In Diagnostics Market
11.7.1. Rest of Asia Pacific Market Size and Forecast, 2022-2033 (USD Million)
11.7.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
11.7.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)

12. Latin America Artificial Intelligence In Diagnostics Market
12.1. Latin America Artificial Intelligence In Diagnostics Market
12.1.1. Latin America Market Size and Forecast, 2022-2033 (USD Million)
12.1.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
12.1.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)
12.2. Brazil Artificial Intelligence In Diagnostics Market
12.2.1. Brazil Market Size and Forecast, 2022-2033 (USD Million)
12.2.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
12.2.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)
12.3. Mexico Artificial Intelligence In Diagnostics Market
12.3.1. Mexico Market Size and Forecast, 2022-2033 (USD Million)
12.3.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
12.3.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)
12.4. Argentina Artificial Intelligence In Diagnostics Market
12.4.1. Argentina Market Size and Forecast, 2022-2033 (USD Million)
12.4.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
12.4.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)
12.5. Rest of Latin America Artificial Intelligence In Diagnostics Market
12.5.1. Rest of Latin America Market Size and Forecast, 2022-2033 (USD Million)
12.5.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
12.5.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)

13. MEA Artificial Intelligence In Diagnostics Market
13.1. MEA Artificial Intelligence In Diagnostics Market
13.1.1. MEA Market Size and Forecast, 2022-2033 (USD Million)
13.1.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
13.1.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)
13.2. GCC Artificial Intelligence In Diagnostics Market
13.2.1. GCC Market Size and Forecast, 2022-2033 (USD Million)
13.2.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
13.2.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)
13.3. South Africa Artificial Intelligence In Diagnostics Market
13.3.1. South Africa Market Size and Forecast, 2022-2033 (USD Million)
13.3.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
13.3.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)
13.4. Rest of MEA Artificial Intelligence In Diagnostics Market
13.4.1. Rest of MEA Market Size and Forecast, 2022-2033 (USD Million)
13.4.1.1. Market Size and Forecast by Component, 2022-2033 (USD Million)
13.4.1.2. Market Size and Forecast by Diagnosis Type, 2022-2033 (USD Million)

14. Competitor Analysis
14.1. Market Share Analysis, 2022
14.2. Major Recent Developments, 2019-2022

15. Company Profiles
15.1. Digital Diagnostics, Inc.
15.1.1. Company Snapshot
15.1.2. Company Overview
15.1.3. Financials
15.1.4. Component Benchmarking
15.1.5. Recent Developments
15.2. AliveCor, Inc.
15.2.1. Company Snapshot
15.2.2. Company Overview
15.2.3. Financials
15.2.4. Component Benchmarking
15.2.5. Recent Developments
15.3. Siemens Healthineers
15.3.1. Company Snapshot
15.3.2. Company Overview
15.3.3. Financials
15.3.4. Component Benchmarking
15.3.5. Recent Developments
15.4. Vuni, Inc.
15.4.1. Company Snapshot
15.4.2. Company Overview
15.4.3. Financials
15.4.4. Component Benchmarking
15.4.5. Recent Developments
15.5. Neural Analytics
15.5.1. Company Snapshot
15.5.2. Company Overview
15.5.3. Financials
15.5.4. Component Benchmarking
15.5.5. Recent Developments
15.6. Zebra Medical Vision, Inc
15.6.1. Company Snapshot
15.6.2. Company Overview
15.6.3. Financials
15.6.4. Component Benchmarking
15.6.5. Recent Developments
15.7. Riverain Technologies
15.7.1. Company Snapshot
15.7.2. Company Overview
15.7.3. Financials
15.7.4. Component Benchmarking
15.7.5. Recent Developments
15.8. GE Healthcare
15.8.1. Company Snapshot
15.8.2. Company Overview
15.8.3. Financials
15.8.4. Component Benchmarking
15.8.5. Recent Developments
15.9. Aidoc
15.9.1. Company Snapshot
15.9.2. Company Overview
15.9.3. Financials
15.9.4. Component Benchmarking
15.9.5. Recent Developments
15.10. Imagen Technologies
15.10.1. Company Snapshot
15.10.2. Company Overview
15.10.3. Financials
15.10.4. Component Benchmarking
15.10.5. Recent Developments
15.11. Company 11
15.11.1. Company Snapshot
15.11.2. Company Overview
15.11.3. Financials
15.11.4. Component Benchmarking
15.11.5. Recent Developments
15.12. Company 12
15.12.1. Company Snapshot
15.12.2. Company Overview
15.12.3. Financials
15.12.4. Component Benchmarking
15.12.5. Recent Developments
15.13. Company 13
15.13.1. Company Snapshot
15.13.2. Company Overview
15.13.3. Financials
15.13.4. Component Benchmarking
15.13.5. Recent Developments
15.14. Company 14
15.14.1. Company Snapshot
15.14.2. Company Overview
15.14.3. Financials
15.14.4. Component Benchmarking
15.14.5. Recent Developments
15.15. Company 15
15.15.1. Company Snapshot
15.15.2. Company Overview
15.15.3. Financials
15.15.4. Component Benchmarking
15.15.5. Recent Developments
15.16. Others Prominent Players

16. Conclusion & Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Digital Diagnostics Inc.
  • AliveCor Inc.
  • Siemens Healthineers
  • Vuni Inc.
  • Neural Analytics
  • Zebra Medical Vision Inc
  • Riverain Technologies
  • GE Healthcare
  • Aidoc
  • Imagen Technologies